Sonita Alizadeh

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

Retrieved on: 
Wednesday, July 6, 2022
FDA, Surgeon, Patient, Breast augmentation, Sonita Alizadeh, GLOBE, American Society for Aesthetic Plastic Surgery, Sale, Company, Goal, United, Woman, Statistics, Food, Clinical trial, Breast, Plastic and Reconstructive Surgery, NASDAQ, Society, Regulation of tobacco by the U.S. Food and Drug Administration, Work, Aesthetic Plastic Surgery, Dentistry, Medical device, MD

SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company) announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.

Key Points: 
  • SANTA BARBARA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (Sientra or the Company) announced today that the U.S. Food and Drug Administration (FDA) approved the Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction.
  • Now when I utilize Sientras new Low Plus Profile Projection Breast Implant, my patients will get the natural look with the upper pole fullnesstheydesire.
  • Sientra will be the first and only implant maker within the United States to offer 80cc and 110cc gel implants.
  • Ten-year core study data for Sientras Food and Drug Administrationapproved round and shaped breast implants with cohesive silicone gel.

Sientra® And Mission Plasticos Launch Reshaping Lives: Full Circle™ A Philanthropic Initiative For Women Living In Poverty In America

Retrieved on: 
Tuesday, October 19, 2021
Mission, Clinical trial, Work, Association, Breast cancer, Use, Surgeon, Sale, Program, Breast, FDA, Poverty, CEO, GLOBE, Patient, Circle, Sonita Alizadeh, Partnership, Plastic and Reconstructive Surgery, Breast reconstruction, Company, Management, Medical imaging, Birth control

SANTA BARBARA, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc., a medical aesthetics company uniquely focused on plastic surgery, and Mission Plasticos, a 501-c3 non-profit organization dedicated to providing reconstructive surgical care to those in medically underserved communities around the globe, today announced the launch of Reshaping Lives: Full Circle, a nationwide program aimed at providing reconstructive breast surgery for post-mastectomy women living in poverty. This is the first phase of Mission Plasticos’ recently announced Reshaping Lives America, the first large-scale, nationwide program providing reconstructive surgical care at no cost to people living in poverty in the U.S., and is being funded through a $1 million donation from Sientra.

Key Points: 
  • Sientra has a rich history of giving back to the community, starting with our Full Circle grant program and now continuing through our support of Mission Plasticos, Reshaping Lives: America initiative, said Ron Menezes, President and CEO of Sientra and Chairman of the Reshaping Lives America Corporate Council.
  • With this partnership, we are pleased to expand and amplify our Full Circle program, which will now become Reshaping Lives: Full Circle.
  • Mission Plasticos will then pair those surgeons with appropriate local patients, at no cost to the patient.
  • The Reshaping Lives: Full Circle, initiative aims to help women in America experiencing these barriers to access a full journey of care.